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ABSTRACT
Objectives To estimate survival after a diagnosis of
dementia in primary care, compared with people without
dementia, and to determine incidence of dementia.
Design Cohort study using data from The Health
Improvement Network (THIN), a primary care database.
Setting 353 general practices in the United Kingdom
providing data to THIN.
Participants All adults aged 60 years or over with a first
ever code for dementia from 1990 to 2007 (n=22529);
random sample of five participants without dementia for
every participant with dementia matched on practice and
time period (n=112645).
Main outcomemeasuresMedian survival by age and sex;
mortality rates; incidence of dementia by age, sex, and
deprivation.
Results The median survival of people with dementia
diagnosed at age 60-69 was 6.7 (interquartile range
3.1-10.8) years, falling to 1.9 (0.7-3.6) years for those
diagnosedat age90 or over. Adjustedmortality rateswere
highest in the first year after diagnosis (relative risk 3.68,
95% confidence interval 3.44 to 3.94). This dropped to
2.49 (2.29 to 2.71) in the second year. The incidence of
recorded dementia remained stable over time (3-4/1000
person years at risk). The incidence was higher in women
and in younger age groups (60-79 years) living in deprived
areas.
ConclusionsMedian survival was much lower than in
screened populations. These clinically relevant estimates
can assist patients and carers, clinicians, and policy
makers when planning support for this population. The
high risk of death in the first year after diagnosis may
reflect diagnoses made at times of crisis or late in the
disease trajectory. Late recording of diagnoses of
dementia in primary care may result in missed
opportunities for potential early interventions.
INTRODUCTION
Dementia is a global condition, and 80 million people
worldwide are predicted to be affected by 2040.1
Dementia syndromes have a huge impact on people
with the illness, and their families and carers, with
substantial health, societal, and economic
consequences.2-4 Among people with dementia, men,
older people, and those with pre-existing comorbid
conditions have decreased life expectancy and survival
in community studies.5-8
Family doctors provide most medical care for peo-
ple with dementia.9 The incidence of dementia in pri-
mary care is expected to rise as the demographic
profile of the population shifts towards older people.
The recording of dementia in the clinical records in
primary care requires both recognition of the problem
by the clinician and the entry of a diagnosis on the
medical record.Most estimates of incidence and survi-
val are based on studies in the community, with active
case finding through the use of structured screening
instruments for dementia.5-8 A recent such study
reported an overall median survival of 4.1 years for
men and4.6 years forwomen.8 Themortality of people
with dementia in such community studies has been
found to be higher than that of people without the
condition.6 10-12 These estimates, however, will differ
from those in populations derived from people
known to their family doctors, where a diagnosis is
recorded only after clinical presentation and recogni-
tion of symptoms.
Diagnosis of dementia often occurs late. The UK’s
national dementia strategy suggests that the United
Kingdom is in the bottom third of performance in Eur-
ope in terms of diagnosis and treatment.13 No large
primary care studies on incidence and survival from
the point of clinical diagnosis have been done to con-
firm this perception. Such studies may offer a more
accurate estimate of the extent of the workload gener-
ated by this population. Primary care clinical databases
afford an unrivalled opportunity to examine the out-
comes of large numbers of people in clinical settings
and provide “real life” estimates of survival in this set-
ting. Survival from the point of recognition of demen-
tia by the clinician may also be of greater relevance to
patients, carers, health professionals, and planners
than are survival data based on screened populations.
* The objectives of this study were to determine inci-
dences of recorded dementia in primary care between
1997 and 2007 and survival from the point of recorded
diagnosis of dementia in comparisonwith people with-
out dementia in the period 1990-2007.
1Medical Research Council General
Practice Research Framework,
London NW1 2ND
2Research Department of Primary
Care and Population Health, UCL
Medical School, Royal Free
Campus, London NW3 2PF
Correspondence to: G Rait
gr@gprf.mrc.ac.uk
Cite this as: BMJ 2010;341:c3584
doi:10.1136/bmj.c3584
BMJ | ONLINE FIRST | bmj.com page 1 of 7
METHODS
In this cohort study, we examined data from general
practices in the UK providing data to The Health
Improvement Network (THIN) during the period Jan-
uary 1990 to August 2007.We used only practices that
met standards for acceptable levels of data recording.
For the survival study, we used data frompractices that
met the criteria for acceptable standards of mortality
reporting.14
Data source
The Health Improvement Network (www.epic-uk.
org/thin.htm) electronic recording scheme is one of
the largest sources of continuous primary care data
on patients’ consultations and prescribing in the UK.
It is a clinical database in which every consultation in
participating practices is recorded and contains the
electronic clinical records of more than 5 million
patients. It has been widely used for epidemiological
studies.15 16 Anonymised patients’ data are collected
from358participating practices that are broadly repre-
sentative of UK general practices in terms of patients’
age and sex, practice size, and geographical
distribution.17 General practitioners record medical
diagnoses and symptoms by using Read codes, a hier-
archical recording system used to record clinical sum-
mary information. The age, sex,medical diagnosis and
symptom records, health promotion activity, referrals
to secondary care, prescriptions, and fifths of depriva-
tion score are recorded for each registered person.
Participants
“Exposed” participants—We included all adults aged
60 years or over with a first ever code for dementia
(as defined below) during the period January 1990 to
August 2007.
“Unexposed” participants—We selected a random
sample of five people without dementia, registered at
the same general practice at the time of diagnosis, for
every person with dementia aged 60 years and over.
Exclusions—We excluded people with a history of
dementia (before study entry) or a dementia syndrome
related to HIV, Pick’s disease, Huntingdon’s disease,
or Parkinson’s disease. We excluded patients’ follow-
up time and diagnoses in the first sixmonths after regis-
tration with a practice. These entries could represent
retrospective recording of medical history rather than
a true incident recording of dementia.18 We also
excluded patients with less than six months of data
from registration with their general practitioner.
Measurements
The study team developed lists of Read codes to iden-
tify recorded diagnoses of dementia. These included
people with codes for non-specific dementia, Alzhei-
mer’s disease, and vascular dementia but did not
include codes for memory symptoms or cognitive
impairment. For the purpose of determining inci-
dence, we examined age by four age bands (60-69,
70-79, 80-89, and 90 and above). We examined depri-
vation by using fifths of Townsend score from 1 (least
deprived) to 5 (most deprived). The Townsend
deprivation score is a combined measure of owner
occupation, car ownership, overcrowding, and unem-
ployment based on a person’s postcode and linkage to
population census data for 2001 for approximately 150
households in that postal area.19 We also collected
information on smoking; heavy alcohol consumption;
and history of diabetes, cardiovascular disease, hyper-
tension, cerebrovascular disease, and high cholesterol.
Analysis
We used Stata version 10 for statistical analyses. To
analyse incidence, we defined cases by using the
Read codes for dementia as described above. We cal-
culated person years at risk contributed to the age
groups by people registered in the THIN database
between 1997 and 2007. People started contributing
person years at risk six months after registration and
stopped contributing at the earliest of study end date,
date of death, date transferred out of the practice, date
of diagnosis of dementia, or three years after their last
consultation. We calculated the incidence of dementia
within age groups for men and women and for fifths of
deprivation.
We used the Kaplan-Meier estimator to estimate the
survival function for the dementia cohort and the com-
parator cohort without dementia, matched on general
practice and time of diagnosis for the period 1990-
2007. We categorised age at diagnosis into five year
age bands and estimated the survival function sepa-
rately for people from each of these age bands. We
censored people if they were transferred out of the
practice, had not consulted in three years, or were
alive at the end of the study period.
We used a conditional Poisson regression model to
compare the death rate of people with and without
dementia. We estimated rate ratios adjusted for age
and sex separately for each year after diagnosis. In a
secondary analysis, we also adjusted the rate ratios for
comorbidities (smoking, heavy alcohol consumption,
Table 1 | Incidence of dementia by age and sex, 1997-2007
Age band
(years)
Women Men
Incidence rate ratio
(95% CI)No
Person years
at risk Incidence* (95% CI) No
Person years
at risk Incidence* (95% CI)
60-69 600 1 122 402 0.53 (0.49 to 0.59) 527 1 086 063 0.49 (0.44 to 0.53) 1.10 (0.98 to 1.24)
70-79 3515 936 166 3.75 (3.63 to 3.88) 2179 774 927 2.81 (2.69 to 2.93) 1.34 (1.27 to 1.41)
80-89 7193 608 358 11.82(11.55to12.10) 3120 366 622 8.51 (8.21 to 8.81) 1.39 (1.33 to 1.45)
≥90 2603 231 523 11.24(10.81to11.67) 672 89 804 7.48 (6.92 to 8.05) 1.50 (1.38 to 1.64)
*Incidence of dementia per 1000 person years at risk.
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diabetes, cardiovascular disease, hypertension, cerebro-
vascular disease, and high cholesterol).
RESULTS
Incidence
Three hundred and fifty-three practicesmet the criteria
for acceptable data recording between January 1997
and August 2007. In total, 20 409 people aged
60 years and over had a diagnosis of dementia
recorded in the study period. The incidence of
recorded dementia remained relatively stable over
time at between 3 and 4 per 1000 person years at risk
(fig 1); the exceptionwas 2006, when the incidencewas
significantly higher at 5/1000 person years at risk.
The incidence of recorded dementia was more than
15 times higher in people aged over 90 compared with
the 60-69 year age group. The incidence was greater in
women than men across all age groups (table 1).
Greater deprivation, compared with lower depriva-
tion, was associated with a higher rate of recorded
dementia in the younger age groups (60-69 and
70-79 years), but this became less marked in the older
age groups (table 2).
Survival
Threehundred and forty-ninepracticesmet the criteria
for acceptable data and mortality recording between
January 1990 and August 2007. These practices had
22 529 people aged 60 years and over with a recorded
diagnosis of dementia (table 3), with 40 424 person
years of follow-up. Two thirds of people with dementia
were female (67.9%), and the mean age was 82.2 (SD
7.4) years.Most peoplewith dementiawere codedwith
a non-specific dementia code (n=14 485; 64.3%); about
a fifth had been given a code of Alzheimer’s disease
(4674; 20.7%), and 15% (3370) had a code of vascular
dementia.
The matched comparison group contained 112645
people aged 60 years and over without dementia, with
432 307 person years of follow-up. This group was
younger (mean age 72.2 (SD 8.6) years) and conse-
quently had a longermedian follow-up time (3.1 (inter-
quartile range 1.4-5.6) years) than did people with
dementia (1.3 (0.5-2.7) years). In the dementia group,
41.6% (n=9372) had died compared with 17.5%
(n=19 713) in the non-dementia group. More than a
quarter of people with dementia transferred out of the
practices (27.5%; n=6195) compared with 10.2%
(n=11 490) of people without dementia.
The median survival of people with a diagnosis of
dementiawas associatedwith age at first recordeddiag-
nosis. Themedian survival for people aged 60-69 years
at diagnosis was 6.7 (interquartile range 3.1-10.8)
years, falling to 1.9 (0.7-3.6) years in those aged
90 years and over (fig 2). The five year survival ranged
from just over 50% in 60-69 year olds to 25% in
80-89 years olds.
Relative mortality—The mortality rate was more than
three times greater in patients with dementia than in
those without dementia in the first year after the diag-
nosis was recorded (relative risk 3.76, 95% confidence
interval 3.57 to 3.97), when adjusted for age and sex
(table 4). The rate fell in subsequent years to about
two and half times greater than that of people without
dementia. Adjustment for comorbidities, deprivation,
smoking, and alcohol had little effect on the rate ratios.
The adjusted relative risk of dying remainedmore than
three and a half times higher in the first year after
dementia was diagnosed (3.68, 3.44 to 3.94).
DISCUSSION
The incidence of recorded dementia in a UK general
practice cohort has remained fairly static over the past
decade at between 3 and 4 per 1000 person years at
risk. This is against a background of efforts to improve
awareness of early diagnosis of dementia in primary
care, including the use of financial incentives to estab-
lish dementia registers in general practice. Incidences
were higher in women and older people, which is con-
sistent with other studies. The incidence was also
higher in people aged 60-79 from the most deprived
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Fig 1 | Incidence of dementia by year from 1997 to 2007
Table 2 | Incidence of dementia by deprivation fifth
Deprivation fifth
Age band (years)
60-69 70-79 80-89 ≥90
1 (low) 0.42 (0.36 to 0.47) 2.87 (2.70 to 3.04) 10.74 (10.27 to 11.21) 11.58 (10.68 to 12.48)
2 0.41 (0.36 to 0.47) 3.01 (2.83 to 3.19) 10.28 (9.83 to 10.73) 11.71 (10.84 to 12.59)
3 0.55 (0.48 to 0.63) 3.32 (3.12 to 3.52) 10.82 (10.36 to 11.29) 11.32 (10.47 to 12.18)
4 0.61 (0.53 to 0.69) 3.97 (3.74 to 4.20) 11.58 (11.08 to 12.08) 12.35 (11.39 to 13.30)
5 (high) 0.70 (0.59 to 0.81) 4.17 (3.88 to 4.46) 11.87 (11.26 to 12.48) 11.48 (10.35 to 12.60)
Rate ratio* 1.68 (1.40 to 2.03) 1.45 (1.34 to 1.58) 1.11 (1.04 to 1.18) 0.99 (0.89 to 1.10)
*Highest versus lowest fifth of deprivation.
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group compared with those from the least deprived
group, but this finding was less marked in older age
groups. The median survival of people with dementia
decreased with age. Mortality rates were more than
three times higher in people with dementia than in
those without dementia in the first year after diagnosis
and more than twice as high from the second to the
sixth year after diagnosis.
Comparison with other studies
Pooled incidence data from four populationbasedEur-
opean studies of people aged 65 years and older found
that the incidence of dementia in women increased
with age from 2.9/1000 person years at risk in the 65-
69 age group to 35.4/1000 person years at risk in those
aged 80-84.20 The overall incidence of dementia in the
Medical Research Council Cognitive Function and
Ageing study in the UK reported rates of 6.3 and
31.2/1000 person years at risk in women in the corre-
sponding age groups.21 The incidences for women in
our study were 0.5 and 11.8 for the 60-69 and
80-89 year age groups, illustrating the lower level of
recognition and recording of dementia in primary
care. The slight increase in incidence in 2006 could
be explained by the introduction of incentive pay-
ments for general practitioners in the UK to record
dementia on practice registers as part of the quality
and outcomes framework.22 UK population projec-
tions suggest that increases in the number of people
with dementia in the community are likely to be
more striking in the forthcoming years than during in
our study period.23
Timely diagnosis for people with dementia can facil-
itate appropriate support and assist family doctors to
organise systematic management. We found much
lower incidences than those reported from the commu-
nity, suggesting that general practitioners’ recognition
of dementia has remained low and has not changed
over time. Evidence suggests that dementia is under-
diagnosed in an estimated50%of primary care patients
over the age of 65 and that diagnosis is related to
severity.24 25 Our results are consistent with primary
care studies that show a lack of skills in making a diag-
nosis of dementia and sharing this with patients.26 This
may explain the under-recording of dementia. Low
levels of recording may also reflect a reluctance to
give patients a label of dementia when the perception
is of minimally effective available treatment. These
findings also question the effectiveness of educational
efforts to improve the recognition of dementia in pri-
mary care in the decade since the introduction of cho-
linesterase inhibitors. This underlines the emphasis on
improving recognition of dementia, as proposed in the
UK’s recently published national dementia strategy.12
Median survival in our study was lower than in stu-
dies of screened populations, but the effects of age and
sex on survival are consistent. Lower survival in our
study is probably explained by the fact that our sample
was identified at a later stage of their illness. Our study
is likely to be identifying people further along the
dementia trajectory, where symptoms or functioning
are potentially affecting the patients, their carers, or
both. A case-control study reviewed 319 general prac-
tice records of people with dementia and found differ-
ences between cases and controls in terms of cognitive
symptoms up to four years before diagnosis.27 Xie and
colleagues examined 438 people with dementia from a
screened population in the UK.8 They found higher
median survival in all age groups than we saw in our
study (65-69 age group 10.7 v 6.9 years; ≥90 age group
3.8 v 1.9 years). This and other studies found higher
median survival in samples identified through active
case finding in the community.10 An alternative expla-
nation for reduced survival might be that diagnoses of
dementia are enteredmore often at times of crisis, such
as after an admission to hospital or comorbid infection
or when cognitive function is rapidly deteriorating.
Our study found a higher relative mortality rate in
the first year after diagnosis (relative risk 3.68). This
may be explained by more diagnostic entries being
made in the primary care record at a time of crisis,
inter-current illness, hospital admission, or previous
admission to an institution. Evidence exists of higher
short term mortality in people with dementia after
acute medical admission.28 More than twice the num-
ber of people with dementia than without dementia
transferred out of practices. This may be due to the
severity of the illness necessitating a move closer to
carers or family or into nursing or residential homes.
These people could not be followed up. If the group
that transferred out was at greater risk of dying, our
Table 3 | Baseline characteristics for participants with and
without dementia in survival study (1990-2007). Values are
numbers (percentages)
Characteristic
Dementia
(n=22 529)
Non-dementia
(n=112 645)
Female 15 305 (67.9) 62 830 (55.8)
Age (years):
60-69 1 397 (6.2) 52 733 (46.8)
70-79 6 725 (29.9) 37 545 (33.3)
80-89 11 249 (49.9) 18 723 (16.6)
≥90 3 158 (14.0) 3 644 (3.2)
Deprivation fifth:
1 (least deprived) 4 318 (19.2) 25 040 (22.2)
2 4 275 (19.0) 23 825 (21.2)
3 4 438 (19.7) 21 195 (18.8)
4 4 386 (19.5) 19 685 (17.5)
5 (most deprived) 3 113 (13.8) 13 891 (12.3)
Not recorded 1 999 (8.9) 9 009 (8.0)
Cardiovascular disease 5 047 (22.4) 23 251 (20.6)
Cerebrovascular disease 6 605 (29.3) 14 927 (13.3)
Diabetes 3 136 (13.9) 16 300 (14.5)
Hypertension 8 706 (38.6) 50 148 (44.5)
High cholesterol 2 513 (11.2) 23 907 (21.2)
Smoking status:
Smoker/ex-smoker 7 121 (31.6) 50 330 (44.7)
Non-smoker 12 518 (55.6) 55 850 (49.6)
Not recorded 2 890 (12.8) 6 465 (5.7)
Alcohol dependency 946 (4.2) 6 395 (5.7)
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study may have overestimated survival. Knowing
where in the disease trajectory diagnoses are being
made is important. Previous studies with screened
populations have also reported lower relative survival
of people with dementia compared with populations
without dementia.5 6 10 12
Strengths and limitations
This study examined the incidenceof recordeddemen-
tia and survival in a large cohort of people seen in UK
primary care. It included data from more than 22 000
new episodes of dementia recorded in routine primary
care settings. We were able to assess survival from the
point of recording a clinical diagnosis of dementia and
compare it against a group of more than 100 000 peo-
ple without dementia. With such a large sample, we
can provide accurate estimates of survival in this set-
ting.Most previous research on incidence of and survi-
val with dementia has been done on smaller
community samples, in which people were actively
screened for dementia.
Our data were based on recorded dementia in gen-
eral practice records. Such data depend not only on the
underlying incidence in the community but also on
patients presenting to family doctors and the doctors
recognising dementia and then entering it in the elec-
tronic records. People with suspected dementia or with
symptoms of dementia and no diagnosis would not
have been included in our sample, and our results
would not apply to these groups. Validation work on
recording of dementia in UK primary care databases
found thatmost (83%)of thediagnosesmadebygeneral
practitioners were confirmed,29 and evidence indicates
that chronic and important medical diagnoses entered
in electronic records are likely to be accurate,3031
including mental health diagnoses.32 We know from
previous work that dementia tends to be under-
recorded in general practice records and that general
practitioners believe that they are not skilled or confi-
dent enough tomake a diagnosis alone and seek specia-
list advice first.24-26 33 We would therefore anticipate
that the diagnosis of dementia in general practice
records has low sensitivity but high specificity. Death
recording in THIN has been shown to be valid.30 Data
from the electronic records donot provide ameasure of
Table 4 | Mortality rate ratios for participants with dementia
compared with those without dementia
Year of follow-up after
diagnosis Rate ratio* (95% CI) Rate ratio† (95% CI)
First 3.76 (3.57 to 3.97) 3.68 (3.44 to 3.94)
Second 2.50 (2.33 to 2.68) 2.49 (2.29 to 2.71)
Third 2.43 (2.22 to 2.66) 2.37 (2.13 to 2.63)
Fourth 2.54 (2.27 to 2.85) 2.48 (2.17 to 2.84)
Fifth 2.62 (2.25 to 3.05) 2.42 (2.02 to 2.90)
Sixth 2.55 (2.08 to 3.12) 2.34 (1.84 to 2.97)
*Adjusted for age and sex.
†Adjusted for age, sex, deprivation, smoking, alcohol, diabetes,
hypertension, cardiovascular disease, cerebrovascular disease, and high
cholesterol.
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the severity of dementia, which is known to influence
survival. Moreover, most codes entered were non-spe-
cific and did not allow for differentiation of subtypes.
We were therefore unable to assess the effect of under-
lying pathology (such as Alzheimer’s disease or vascu-
lar dementia) on survival. General practitioners may
use uncoded free text options in the electronic records.
Such text may include entries on dementia but would
not have been identified in our search, resulting in an
underestimate of the incidence. Adjustment for comor-
bidities produced little effect on the risk of death. This
may be explained by under-recording of certain
comorbidities in people with dementia, as they may
be less likely to be investigated than other people with
chronic diseases. For example, in our study, people
with dementiaweremore likely to be diagnosed as hav-
ing cerebrovascular disease but less likely to be
recorded as having high cholesterol. However, life
expectancy among people with dementia may be pre-
dominantly determined by dementia rather than by
comorbidities. Although we had large numbers in the
survival study, smaller numberswere available for long
term follow-up.
Implications
Our study reports on people who were identified as
having dementia by their general practitioners and
who had this entered in their electronic record.Nopre-
vious research reporting on this population has been
published. Our findings contrast with data from exist-
ing cohorts that tend to relate to survival from early in
the disease trajectory. This is important information
for both practitioners and commissioners in the plan-
ning of health and social care, including palliative care
services.
Our study supports the view that under-recognition
of dementia syndromes persists in primary care, and
that greater engagement of primary care in earlier
andbetter detectionof dementia is needed. In addition,
we found that general practitioners often record the
diagnosis of dementia in a non-specific way, not differ-
entiating between Alzheimer’s disease and vascular
dementia. This is an important distinction that may
affect management, including the use of anti-
cholinesterase inhibitors, and should be covered in
educational initiatives or through incentives. The
point of primary care recording of a diagnosis is likely
to be the start of a period in which greater demands are
made on the primary and secondary healthcare teams
and on social care. Further work is needed to explore
factors underlying the decision of general practitioners
to record a diagnosis of dementia and enter it on a
dementia register, as well as why the mortality rates
are higher in the first year after formal recording of a
diagnosis. The information from this study may assist
clinicians in providing information to patients and
carers on median survival times at the point of diagno-
sis in primary care andmay also aid policymakers and
providers in planning services. These findings could
assist future work on estimating workload and costs
related to this period from clinical diagnosis onwards
and inform modelling of the effect of dementia on
health and social care services.
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